Conduit Pharmaceuticals Inc. (CDT) Dividend History

Company News

• Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes

  Conduit Pharmaceuticals has restructured a $2.65 million loan note with Nirland Limited, removing restrictive clauses and making the note convertible. The company has also secured $1.2 million in new promissory notes, positioning it to access its At-The-Market (ATM) facility to support its note repayment obligations, operations, and clinical objectives.

  GlobeNewswire Inc.
• Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Benzinga

  Bloom Energy shares jumped 12.1% after announcing a strategic partnership with CoreWeave to deploy its fuel cells for on-site power generation at a data center. Several other stocks also saw significant pre-market movements, both positive and negative.

  Benzinga

  Featured Companies: ADVM APVO BE CERS FIVE GTLB IMMR LPA MLGO OCTO SHIM SIEB SILO
• What Happened With Conduit Pharmaceuticals (CDT) Stock Today? - Benzinga

  Conduit Pharmaceuticals shares traded higher by over 50% after the company announced it received patent approval for its lead asset targeting autoimmune diseases, which allows it to participate in the Patent Prosecution Highway and enhances the likelihood of approvals in major jurisdictions.

  Benzinga
• Why Match Group Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga

  Match Group shares jumped 8% in pre-market trading after Starboard Value took a stake of over 6.5% in the company and is advocating for a potential sale. Several other stocks also saw significant pre-market movement.

  Benzinga

  Featured Companies: AEON AMIX AREB CHGG DATS DJT GRNQ MTCH OPEN QLGN UAVS WNW
• Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub

  SAN DIEGO and LONDON, March 11, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals" or "Conduit") today announced the opening of cutting-edge laboratory space in Cambridge, United Kingdom, a global centre for research and development for companies at the forefront of life science innovation. This strategic acquisition marks a pivotal milestone for Conduit, positioning the Company for portfolio expansion, enhanced development capabilities, and growth of a robust intellectual property portfolio.

  GlobeNewswire Inc.